The Center for Digestive Care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has been established with a mission to provide high-quality patient care, research and education for all aspects of digestive disease. It offers innovative treatments and coordinated care for conditions ranging from gastrointestinal reflux and hepatitis C to colon cancer and metabolic surgery, a new field that focuses on reversing Type 2 diabetes.
The Center was made possible through gifts totaling $65 million from The Leona M. and Harry B. Helmsley Charitable Trust to NewYork-Presbyterian Hospital/Weill Cornell Medical Center -- among the largest earmarked specifically for advancing treatment of digestive diseases. These gifts were announced at earlier dates.
"Close to 70 million Americans suffer from a digestive disorder, and as our population ages, the number of those affected will continue to rise," says Dr. Jeffrey Milsom, executive director of the Center. "Our Center is designed to address this need by offering the latest and most effective treatment options, as well as preventive strategies, available in a safe and supportive environment that emphasizes the needs of patients and their families."
Among the treatments offered are radiofrequency ablation to avoid surgery for patients suffering from Barrett's esophagus; minimally invasive surgery for morbid obesity, inflammatory bowel disease, ulcerative colitis, Crohn's disease, colon cancer and metabolic disorders; advanced endoscopic techniques for diagnosing and treating GERD (gastrointestinal reflux disease); and novel therapies aimed at preventing esophageal, pancreatic and colon cancer using biomarkers and genetic testing.
Nurse Coordinators Streamline Patient Care